412 related articles for article (PubMed ID: 15388461)
1. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
[TBL] [Abstract][Full Text] [Related]
3. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
5. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
[TBL] [Abstract][Full Text] [Related]
7. Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.
Merrigan MM; Sambol SP; Johnson S; Gerding DN
J Infect Dis; 2003 Dec; 188(12):1922-7. PubMed ID: 14673773
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies for C. difficile associated diarrhea.
Stepan C; Surawicz CM
Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
[TBL] [Abstract][Full Text] [Related]
11. Past, present, and future therapies for Clostridium difficile-associated disease.
Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
Freeman J; Baines SD; Jabes D; Wilcox MH
J Antimicrob Chemother; 2005 Oct; 56(4):717-25. PubMed ID: 16143709
[TBL] [Abstract][Full Text] [Related]
13. Use of vancomycin hydrochloride for treatment of Clostridium difficile enteritis in Syrian hamsters.
Boss SM; Gries CL; Kirchner BK; Smith GD; Francis PC
Lab Anim Sci; 1994 Feb; 44(1):31-7. PubMed ID: 8007657
[TBL] [Abstract][Full Text] [Related]
14. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Lv Z; Peng G; Liu W; Xu H; Su J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
[TBL] [Abstract][Full Text] [Related]
15. Infection of hamsters with epidemiologically important strains of Clostridium difficile.
Sambol SP; Tang JK; Merrigan MM; Johnson S; Gerding DN
J Infect Dis; 2001 Jun; 183(12):1760-6. PubMed ID: 11372028
[TBL] [Abstract][Full Text] [Related]
16. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Cornely OA; Miller MA; Fantin B; Mullane K; Kean Y; Gorbach S
J Clin Oncol; 2013 Jul; 31(19):2493-9. PubMed ID: 23715579
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
[TBL] [Abstract][Full Text] [Related]
18. [Relapsing infections with Clostridium difficile].
Visser WE; Dingemans-Dumas AM; Bac DJ
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
Berman AL
J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
[No Abstract] [Full Text] [Related]
20. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]